Robert E. Hoffman
DirectoratTuHURA Biosciences, Inc./NV· In proxies 2022–2025
Pay in FY2023-63% from the year before · TuHURA Biosciences, Inc./NV stock -97.5% the same year
Robert E. Hoffman was paid $1.2M in FY2023 (Dec), down 63%. TuHURA Biosciences, Inc./NV stock fell 97.5% that year.
Pay$100 in the stock at the end of FY21 → $1
Experience
- TuHURA Biosciences, Inc./NVPublic company · 4 yr
- Director2022 – Present · 4 yrStock in role -100%
- Esperion TherapeuticsPublic company · 1 yr
- Director2025 – Present · 1 yrNo stock prices for these years
- FibroGenesisPublic company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- Antibe Therapeutics Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- ASLAN Pharmaceuticals, Inc.Public company
- Director? – PresentNo stock prices for these years
- Aravive, Inc.Public company
- Director? – PresentNo stock prices for these years
- CombiMatrix CorporationPublic company
- Director? – PresentNo stock prices for these years
- Compensation Committee of Antibe Therapeutics Inc.Public company
- Director? – PresentNo stock prices for these years
- Financial Executives InternationalPublic company
- Director? – PresentNo stock prices for these years
- MabVax Therapeutics Holdings, Inc.Public company
- Director? – PresentNo stock prices for these years
- Saniona ABPublic company · 1 yr
- Director2021 – 2022 · 1 yrNo stock prices for these years
- Kura Oncology, Inc.Public company · 6 yr
- Director2015 – 2021 · 6 yrNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
Two people shown as one, or a wrong number?